Sort
82,697 grants matching “vaccine development”
Modulation of Human Cells by Virulent Francisella tularensis
$684,269Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Sinusitis in Children and the Nasopharyngeal Microbiome
$684,241Ellen R. Wald · University Of Wisconsin-Madison · R01 · FY2016 · AI
An HB Vaccine Model For HIV Vaccine Trials in Drug Users
$684,213University Of Texas Hlth Sci Ctr Houston · R01 · FY2003 · DA
Resource fo Nonhuman Primate Cell Depleting Antibodies
$684,206Diogo Magnani · Univ Of Massachusetts Med Sch Worcester · R24 · FY2019 · OD
Resource fo Nonhuman Primate Cell Depleting Antibodies
$684,206Diogo Magnani · Univ Of Massachusetts Med Sch Worcester · R24 · FY2018 · OD
Resource fo Nonhuman Primate Cell Depleting Antibodies
$684,206Keith A Reimann · Univ Of Massachusetts Med Sch Worcester · R24 · FY2016 · OD
Assessing ADCC and Fc-mediated Protection against HIV
$684,196David T Evans · University Of Wisconsin-Madison · R01 · FY2019 · AI
Biochemical Mechanism of HIV DNA Integration
$684,163Alan N. Engelman · Dana-Farber Cancer Inst · R37 · FY2020 · AI
Macrophage-targeting Nanoplatforms as Immunotherapy against Pulmonary Infections
$684,136Michael J Sailor · University Of California, San Diego · R01 · FY2024 · AI
Clinical Core
$684,090Duke University · U01 · FY2005 · AI
Clinical Core
$684,090Raphael Dolin · Duke University · U19 · FY2006 · AI
Development of FcRn-Targeted Nanoparticles for Efficient Oral Delivery of Insulin
$684,066Omid C Farokhzad · Brigham And Women'S Hospital · R01 · FY2014 · EB
Rhesus Breeding Colony in Nepal and Importation to USA
$684,040Southwest Foundation For Biomedical Res · P40 · FY2004 · RR
Regulation of memory CD8 T cell development
$684,000Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2023 · AI
Regulation of memory CD8 T cell development
$684,000Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2024 · AI
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation
$683,986Cheryl A London · Tufts University Boston · U01 · FY2024 · CA
Using combination adjuvants to direct and control immune responses at the intestinal mucosa
$683,976James B McLachlan · Tulane University Of Louisiana · U01 · FY2018 · AI
Investigating the role of maternal-fetal crosstalk on neonatal immunity in COVID-19 infection or vaccination in pregnancy
$683,909Stephanie Lina Gaw · University Of California, San Francisco · R01 · FY2023 · HD
A. L. lactis-based vaccine for children with broad spectrum for enteric pathogens
$683,858Marcela F Pasetti · University Of Maryland Baltimore · R01 · FY2010 · AI
COVID-19 Vaccinations and School / Community Resources: Children's Longitudinal Health and Education Outcomes Using Linked Administrative Data
$683,828Brian Elbel · New York University School Of Medicine · U01 · FY2023 · NR
Developing a multi-component vaccine harnessing potent antibody and cellular responses against the blood-stage of Plasmodium falciparum
$683,786Prakash Srinivasan · Johns Hopkins University · R01 · FY2022 · AI
A TB Vaccine for AIDS Patients
$683,780Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2010 · AI
Role of preexisting immunity on airborne transmission of influenza viruses
$683,741Seema S. Lakdawala · Emory University · R01 · FY2025 · AI
A novel vaccine to prevent HCV infection and hence liver cancer
$683,700Ellen S Vitetta · Ut Southwestern Medical Center · RC2 · FY2009 · CA
The Epigenetic Enzyme CARM1 as a Negative Regulator of Dendritic cells and CD8 T cells in Melanoma
$683,670Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2025 · CA